Latest Share Chat

Avacta Group Share News (AVCT)

Avacta Group Information

Buy AVCT Shares
Add AVCT to Watchlist
Add AVCT to Alert

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 41.75

Bid: 41.50

Ask: 42.00

Change: -1.45 (-3.36%)

Spread: 0.50 (1.205%)

Open: 42.75

High: 42.75

Low: 41.50

Prev. Close: 43.20

Last checked at -

Avacta gets MHRA registration for rapid Covid-19 test

Mon, 07th Jun 2021 10:11

(Sharecast News) - Diagnostics and cancer therapy developer Avacta Group announced on Monday that the Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed registration of its 'AffiDX' SARS-CoV-2 antigen lateral flow test for Covid-19, allowing it to place the product on the market in the UK for professional use.
The AIM-traded firm said lateral flow antigen tests are intended to provide a cost-effective and rapid means of identifying individuals with a high viral load, that means they were more likely to infect others.

It said the clinical data for its AffiDX antigen lateral flow test reported in April demonstrated 100% sensitivity for identifying infectious individuals with viral loads measured by PCR of Ct

More News

7 Sep 2020 14:28

IN BRIEF: Avacta To Launch SARS-CoV-2 Elisa Laboratory Test

7 Sep 2020 12:55

Avacta launching Covid-19 laboratory test

(Sharecast News) - Biotherapeutics company Avacta Group announced on Monday that it will launch an 'ELISA' laboratory test for the SARS-CoV-2 spike protein, to support global research efforts into the coronavirus that causes Covid-19.

2 Sep 2020 15:50

IN BRIEF: Avacta Expands Covid-19 Saliva Test Manufacturing Capacity

2 Sep 2020 13:37

Avacta signs Covid-19 test manufacturing deal with Abingdon

(Sharecast News) - Biotherapeutics company Avacta Group has entered into an agreement with Abingdon Health for the manufacture of its saliva-based rapid SARS-CoV-2 antigen test, it announced on Wednesday, as part of its ongoing expansion of manufacturing capacity.

18 Aug 2020 10:39

Avacta Expands Development Agreement With LG Chem Life Sciences

17 Aug 2020 20:07

IN BRIEF: Avacta Not Involved With Medusa 19's Covid Antibody Test

11 Aug 2020 14:18

IN BRIEF: Avacta Names New Life Sciences Chief Development Officer

7 Aug 2020 11:11

Avacta to collaborate with Liverpool School of Tropical Medicine on Covid-19 test

(Sharecast News) - Avacta Group has entered into a collaboration with the Liverpool School of Tropical Medicine (LSTM), it announced on Friday, to clinically validate the rapid saliva-based coronavirus antigen test it is developing with Cytiva.

7 Aug 2020 10:45

UK WINNERS & LOSERS SUMMARY: Hikma Shines After Raising Sales Guidance

7 Aug 2020 09:53

Avacta Collaborates With Liverpool School For Covid-19 Test Validation

6 Aug 2020 14:58

IN BRIEF: Avacta Appoints BBI Solutions To Manufacture Covid Test Kit

6 Aug 2020 10:39

Avacta appoints BBI Solutions as manufacturing partner for Covid-19 antigen test

(Sharecast News) - Biotechnology company Avacta on Thursday appointed BBI Solutions as a manufacturing partner for the development of its rapid SARS-CoV-2 antigen test.

29 Jul 2020 19:01

IN BRIEF: Avacta Expands Partnership With Daewoong Pharmaceutical

29 Jul 2020 13:46

Avacta expands partnership with Daewoong to Covid-19 therapy

(Sharecast News) - Biotherapeutics and reagents developer Avacta Group announced an expansion of its collaboration and license agreement with Daewoong Pharmaceutical and AffyXell Therapeutics - the joint venture established in South Korea by the two companies - to develop stem cell treatments on Wednesday.

22 Jul 2020 17:57

Latest Share Chat

Avacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Avacta gets MHRA registration for rapid Covid-19 test

Login to your account

Quickpicks are a member only feature

Login to your account